Global OTC Consumer Health Products (Powder Form) Market: Snapshot
The global market for over-the-counter health products of powder form is projected to experience incremented demand at a CAGR of 3.6% during the forecast period of 2017 to 2025, which is primarily a reflection of growing awareness among the consumers regarding the prevalence of lifestyle diseases. In addition to that, escalating percentage of geriatric population, increasing disposable income, deep penetration of social media, and fitness trends are augmenting the demand in the global OTC consumer health products market. On the other hand, adverse effects of some of the supplements, the lack of valid literature, and counterfeit pharmaceuticals are hindering the market from attaining its true potential. The report estimates the global OTC consumer health products market to be worth US$40.6 bn by the end of the forecast period, which is 2025.
Nutritional Supplements Emerge as Leading Indication Segment
Based on indication, this TMR report segments the global OTC consumer health products market into skin care products, oral care products, nutritional supplements, gastrointestinal products, and wound care management products. In 2016, the nutritional supplements segment served the maximum demand, and is expected to remain most fruitful aspect of the market throughout the forecast period, which is primarily attributed to the growing demand for vitamins and dietary supplements and the sports nutrition products. The report observes that health conscience is increasing among the urban population as a result of changing lifestyle, growing percentage of geriatric population, increasing disposable income, and widespread penetration of social media. On the other hand, the gastrointestinal products segment is expected to sustain its position as second most important segment, as a result of increasing heartburns.
North America to Sustain Position as Most Profitable Region
Out of five major regions evaluated by this report: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa, the OTC consumer health products market earns maximum demand from North America, which houses two developed countries in the U.S. and Canada. In the near future, North America is expected to maintain its leading position, as a result of high adoption rate of OTC products, changing lifestyle choices, growing demand for healthier options, and escalating geriatric population. In addition to that, as a number of leading players have headquarters in the U.S., strategic acquisitions is expected to reshape the competitive landscape of OTC consumer health products market in North America.
Europe, currently, is the second most lucrative region, with Germany as the leading revenue generating country, although vastly populated region of Asia Pacific is projected to increment the demand for OTC consumer health products market at most robust CAGR during the forecast period of 2017 to 2025. In the near future, two of the most promising emerging economies, India and China, are expected to turn Asia Pacific into a goldmine for the vendors operating in the global OTC consumer health products market.
Some of the key companies currently operating in the global market for over-the-counter consumer health products of power form market are: Pfizer, Inc., Piramal Enterprises Ltd., Abbott Laboratories, Bayer AG, Sun Pharmaceuticals Ltd., GlaxosmithKline plc, Johnson & Johnson, Ipsen, Sanofi S.A., American Health, and Glenmark Pharmaceuticals Ltd. In the near future, development of new products that have fewer to no side effects, imparting awareness via social media and aggressive marketing, and geographical expansion is expected to be the common strategies by the key companies to expand their horizon and cope up with the intense competition.
The OTC Consumer Health Products (Powder Form) Market has been segmented as follows:
|
by Indication |
|
|
by Distribution Channel |
|
|
by Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global OTC Consumer Health Products (Powder Form) Analysis and Forecasts,2015–2025
4.5. Market Outlook
4.6. Porter's Five Forces Analysis
4.7. Value Chain Analysis
4.8. Regulatory Scenario
4.9. Factors influencing Rx to OTC Switch
5. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Indication
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast By Indication, 2015–2025
5.3.1. Skin Care products
5.3.2. Nutritional Supplement Products
5.3.3. Oral Care Products
5.3.4. Wound Care Management Products
5.3.5. Gastrointestinal Products
5.3.6. Others
5.4. Market Attractiveness, By Indication
6. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Distribution Channel, 2015–2025
6.3.1. Hospital Pharmacy
6.3.2. Independent Pharmacies and Retail Stores
6.3.3. Hypermarkets & Supermarkets
6.3.4. Online Sales
6.3.5. Others
6.4. Market Attractiveness By Distribution Channel
7. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Region
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Size (US$ Mn) Forecast, By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East & Africa
7.4. Market Attractiveness By Region
8. North America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast By Country, 2015-2025
8.2.1. U.S.
8.2.2. Canada
8.3. Market Size (US$ Mn) Forecast, By Indication
8.3.1. Skin Care products
8.3.2. Nutritional Supplement Products
8.3.3. Oral Care Products
8.3.4. Wound Care Management Products
8.3.5. Gastrointestinal Products
8.3.6. Others
8.4. Market Size (US$ Mn) Forecast, By Distribution Channel
8.4.1. Hospital Pharmacy
8.4.2. Independent Pharmacies and Retail Stores
8.4.3. Hypermarkets & Supermarkets
8.4.4. Online Sales
8.4.5. Others
8.5. Market Attractiveness Analysis
8.5.1. By Country
8.5.2. By Indication
8.5.3. By Distribution Channel
9. Europe OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Country, 2015-2025
9.2.1. U.K.
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Market Size (US$ Mn) Forecast, By Indication
9.3.1. Skin Care products
9.3.2. Nutritional Supplement Products
9.3.3. Oral Care Products
9.3.4. Wound Care Management Products
9.3.5. Gastrointestinal Products
9.3.6. Others
9.3.7. Market Size (US$ Mn) Forecast, By Distribution Channel
9.3.8. Hospital Pharmacy
9.3.9. Independent Pharmacies and Retail Stores
9.3.10. Hypermarkets & Supermarkets
9.3.11. Online Sales
9.3.12. Others
9.4. Market Attractiveness Analysis
9.4.1. By Country
9.4.2. By Indication
9.4.3. By Distribution Channel
10. Asia Pacific OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Key Trends
10.2. Market Value Forecast By Country, 2015-2025
10.2.1. India
10.2.2. China
10.2.3. Japan
10.2.4. Australia & New Zealand
10.2.5. Rest of Asia Pacific
10.3. Market Size (US$ Mn) Forecast, By Indication
10.3.1. Skin Care products
10.3.2. Nutritional Supplement Products
10.3.3. Oral Care Products
10.3.4. Wound Care Management Products
10.3.5. Gastrointestinal Products
10.3.6. Others
10.4. Market Size (US$ Mn) Forecast, By Distribution Channel
10.4.1. Hospital Pharmacy
10.4.2. Independent Pharmacies and Retail Stores
10.4.3. Hypermarkets & Supermarkets
10.4.4. Online Sales
10.4.5. Others
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Indication
10.5.3. By Distribution Channel
11. Latin America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Country, 2015-2025
11.2.1. Brazil
11.2.2. Mexico
11.2.3. Rest of Latin America
11.3. Market Size (US$ Mn) Forecast, By Indication
11.3.1. Skin Care products
11.3.2. Nutritional Supplement Products
11.3.3. Oral Care Products
11.3.4. Wound Care Management Products
11.3.5. Gastrointestinal Products
11.3.6. Others
11.4. Market Size (US$ Mn) Forecast, By Distribution Channel
11.4.1. Hospital Pharmacy
11.4.2. Independent Pharmacies and Retail Stores
11.4.3. Hypermarkets & Supermarkets
11.4.4. Online Sales
11.4.5. Others
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Indication
11.5.3. By Distribution Channel
12. Middle East & Africa OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Key Trends
12.2. Market Value Forecast By Country, 2015-2025
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of Middle East & Africa
12.3. Market Size (US$ Mn) Forecast, By Indication
12.3.1. Skin Care products
12.3.2. Nutritional Supplement Products
12.3.3. Oral Care Products
12.3.4. Wound Care Management Products
12.3.5. Gastrointestinal Products
12.3.6. Others
12.4. Market Size (US$ Mn) Forecast, By Distribution Channel
12.4.1. Hospital Pharmacy
12.4.2. Independent Pharmacies and Retail Stores
12.4.3. Hypermarkets & Supermarkets
12.4.4. Online Sales
12.4.5. Others
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Indication
12.5.3. By Distribution Channel
13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company (2016)
13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Pfizer, Inc.
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Business Overview
13.3.1.3. Product Portfolio
13.3.1.4. Financial Overview
13.3.1.5. SWOT Analysis
13.3.1.6. Strategic overview
13.3.2. GlaxoSmithKline plc
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Business Overview
13.3.2.3. Product Portfolio
13.3.2.4. Financial Overview
13.3.2.5. SWOT Analysis
13.3.2.6. Strategic overview
13.3.3. Johnson & Johnson
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Business Overview
13.3.3.3. Product Portfolio
13.3.3.4. Financial Overview
13.3.3.5. SWOT Analysis
13.3.3.6. Strategic overview
13.3.4. Sun Pharmaceuticals Ltd.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Business Overview
13.3.4.3. Product Portfolio
13.3.4.4. Financial Overview
13.3.4.5. SWOT Analysis
13.3.4.6. Strategic overview
13.3.5. Piramal Enterprises Ltd.
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Business Overview
13.3.5.3. Product Portfolio
13.3.5.4. Financial Overview
13.3.5.5. SWOT Analysis
13.3.5.6. Strategic overview
13.3.6. Abbott Laboratories
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Business Overview
13.3.6.3. Product Portfolio
13.3.6.4. Financial Overview
13.3.6.5. SWOT Analysis
13.3.6.6. Strategic overview
13.3.7. Ipsen
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Business Overview
13.3.7.3. Product Portfolio
13.3.7.4. Financial Overview
13.3.7.5. SWOT Analysis
13.3.7.6. Strategic overview
13.3.8. Bayer AG
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Business Overview
13.3.8.3. Product Portfolio
13.3.8.4. Financial Overview
13.3.8.5. SWOT Analysis
13.3.8.6. Strategic overview
13.3.9. Sanofi S.A
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Business Overview
13.3.9.3. Product Portfolio
13.3.9.4. Financial Overview
13.3.9.5. SWOT Analysis
13.3.9.6. Strategic overview
13.3.10. Glenmark Pharmaceuticals Limited
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Business Overview
13.3.10.3. Product Portfolio
13.3.10.4. Financial Overview
13.3.10.5. SWOT Analysis
13.3.10.6. Strategic overview
13.3.11. American Health, Inc.
13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.11.2. Business Overview
13.3.11.3. Product Portfolio
13.3.11.4. Financial Overview
13.3.11.5. SWOT Analysis
13.3.11.6. Strategic overview
List of Tables
Table 01: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 02: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 03: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 05: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 06: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 07: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 08: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 09: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 11: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 12: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 13: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication,
Table 15: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 18: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
List of Figures
Figure 01: Global OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%), and Forecast, 2017–2025
Figure 02: Market Value Share By Indication (2017)
Figure 03: Market Value Share By Distribution Channel (2017)
Figure 04: Market Value Share By Region (2017)
Figure 05: Porter's Five Force Analysis
Figure 06: Value Chain Analysis
Figure 07: Factors considered for successful Rx to OTC switch
Figure 08: OTC Drug approval process – U.S.
Figure 09: OTC Drug approval process in Japan
Figure 10: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 11: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Skin Care, 2015–2025
Figure 12: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nutritional Supplements, 2015–2025
Figure 13: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Oral Care, 2015–2025
Figure 14: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wound Care Management, 2015–2025
Figure 15: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Gastrointestinal products, 2015–2025
Figure 16: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Other products, 2015–2025
Figure 17: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Indication
Figure 18: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 19: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hospital Pharmacy, 2015–2025
Figure 20: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Pharmacies & Retail Stores, 2015–2025
Figure 21: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hypermarkets & Supermarkets, 2015–2025
Figure 22: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2015–2025
Figure 23: Global Others Market Revenue (US$ Mn), and Y-o-Y Growth (%), 2015–2025
Figure 24: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Distribution Channel
Figure 25: Global OTC Consumer Health Products (powder form) Market Revenue, US$ Mn, 2015–2025
Figure 26: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Region, 2016 and 2025
Figure 27: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Region
Figure 28: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 29: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 30: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 31: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 32: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 33: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 34: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 35: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 36: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 37: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 38: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 39: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 40: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 41: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 42: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 43: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 44: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 45: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 46: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 47: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 48: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 49: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 50: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 51: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 52: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 53: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel,
Figure 54: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 55: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 56: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 57: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 58: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 59: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 60: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 61: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 62: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 63: Global OTC Consumer Health Products (powder form) Market Share Analysis, by Company (2016)
Figure 64: Pfizer, Inc., Breakdown of Net Sales (2016), by Region
Figure 65: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 66: GlaxoSmithKline plc, Breakdown of Net Sales, by Segment, 2016
Figure 67: GlaxoSmithKline plc, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Johnson & Johnson, Breakdown of Net Sales, by Region, 2016
Figure 69: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 70: Sun Pharmaceuticals Ltd., Breakdown of Net Sales, by Region, 2016
Figure 71: Sun Pharmaceuticals Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 72: Piramal Enterprises Ltd., Breakdown of Net Sales, by Business Segment, 2016
Figure 73: Piramal Enterprises Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 74: Abbott Laboratories, Breakdown of Net Sales (%Share), by Region (2016)
Figure 75: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 76: Ipsen, Breakdown of Net Sales, by Segment, 2016
Figure 77: Ipsen, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 78: Bayer AG, Breakdown of Net Sales (%), by Region (2016)
Figure 79: Bayer AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2016
Figure 80: Sanofi S.A, Breakdown of Net Sales, by Region, 2016
Figure 81: Sanofi S.A, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 82: Glenmark Pharmaceuticals Limited, Breakdown of Net Sales, by Region, 2016
Figure 83: Glenmark Pharmaceuticals Limited, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
OTC Consumer Health Products (Powder Form) Market
*86 figures and 60 tables includes